Novel risk factors for acute kidney injury

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 6, 2014, Pages 560-569

  Varrier, Matt ^a   Ostermann, Marlies ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute kidney injury; Genetics; Hyperuricaemia; Obesity; Risk factor

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; CHLORIDE; CHLORINE; HETASTARCH; URIC ACID;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; AQUEOUS SOLUTION; ARTIFICIAL VENTILATION; DISEASE ASSOCIATION; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETICS; HEMODYNAMIC STRESS; HEREDITY; HIGH RISK PATIENT; HUMAN; HYPERCHLOREMIA; HYPERURICEMIA; HYPOALBUMINEMIA; KIDNEY FUNCTION; META ANALYSIS (TOPIC); MOLECULAR WEIGHT; NEPHROTOXICITY; OBESITY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL PATIENT; SYSTEMATIC REVIEW (TOPIC); ACUTE KIDNEY INJURY; COMORBIDITY; PROGNOSIS;

ACUTE KIDNEY INJURY; COMORBIDITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84927659816     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000061     Document Type: Review

References (68)

1. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380:756-766.
2. Bedford M, Stevens PE, Wheeler TW, Farmer CK. What is the real impact of acute kidney injury? BMC Nephrol 2014; 15:95-103.
3. Lopez-Olivo MA, Pratt G, Palla SL, Salahudeen A. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis 2013; 62:481-492.
4. Ejaz AA, Mu W, Kang DH, et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2007; 2:16-21.
5. Ejaz AA, Beaver TM, Shimada M, et al. Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients? Am J Nephrol 2009; 30:425-429.
6. Lapsia V, Johnson RJ, Dass B, et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med 2012; 125:302.e9-302.e17.
7. Ejaz AA, Kambhampati G, Ejaz NI, et al. Postoperative serum uric acid and acute kidney injury. J Nephrol 2012; 25:497-505.
8. Park SH, Shin WY, Lee EY, et al. The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J 2011; 75:692-697.
9. Roncal CA, Mu W, Croker B, et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2007; 292:F116-F122.
10. Ejaz AA, Dass B, Lingegowda V, et al. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urol Nephrol 2013; 45:449-458.
11. Joannidis M, Wiedermann CJ. Hypoalbuminemia as a risk factor for acute kidney injury. In: Annual update in intensive care and emergency medicine 2011. Berlin, Germany: Springer; 2011. pp. 233-241.
12. Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 2010; 36:1657-1665.
13. Lee EH, Ryul Kim H, Baek SH, et al. Risk factors of postoperative acute kidney injury in patients undergoing esophageal cancer surgery. J Cardiothorac Vasc Anesth 2014; 28:948-954.
14. Lee EH, Baek SH, Chin JH, et al. Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery. Intensive Care Med 2012; 38:1478-1486.
15. Kim CS, Oak CY, Kim HY, et al. Incidence, predictive factors, and clinical outcomes of acute kidney injury after gastric surgery for gastric cancer. PLoS One 2013; 8:e82289.
16. Rodriguez E, Soler MJ, Rap O, et al. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One 2013; 8:e82992.
17. Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370:1412-1421.
18. Cardinal-Fernandez P, Ferruelo A, Martin-Pellicer A, et al. Genetic determinants of acute renal damage risk and prognosis: a systematic review. Med Intensiva 2012; 36:626-633.
19. Jaber BL, Rao M, Guo D, et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004; 25:212-219.
20. Perianayagam MC, Liangos O, Kolyada AY, et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18:255-263.
21. du Cheyron D, Fradin S, Ramakers M, et al. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients. Crit Care Med 2008; 36:3178-3183.
22. Kolyada AY, Tighiouart H, Perianayagam MC, et al. A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int 2009; 75:1322-1329.
23. Alam A, O'Connor DT, Perianayagam MC, et al. Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract 2010; 114:c253-c259.
24. Chang CF, Lu TM, Yang WC, et al. Gene polymorphisms of interleukin-10 and tumor necrosis factor-alpha are associated with contrast-induced nephropathy. Am J Nephrol 2013; 37:110-117.
25. Frank AJ, Sheu CC, Zhao Y, et al. BCL2 genetic variants are associated with acute kidney injury in septic shock. Crit Care Med 2012; 40:2116-2123.
26. Perianayagam MC, Tighiouart H, Liangos O, et al. Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes. Kidney Int 2012; 82:909-919.
27. Susantitaphong P, Perianayagam MC, Kang SW, et al. Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a casecontrol and longitudinal cohort study. Nephron Clin Pract 2012; 122:107-113.
28. Cardinal-Fernandez P, Ferruelo A, El-Assar M, et al. Genetic predisposition to acute kidney injury induced by severe sepsis. J Crit Care 2013; 28:365-370.
29. Susantitaphong P, Perianayagam MC, Tighiouart H, et al. Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury. Nephron Clin Pract 2013; 123:67-73.
30. MacKensen GB, Swaminathan M, Ti LK, et al. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg 2004; 78:520-526.
31. Stafford-Smith M, Podgoreanu M, Swaminathan M, et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005; 45:519-530.
32. Isbir SC, Tekeli A, Ergen A, et al. Genetic polymorphisms contribute to acute kidney injury after coronary artery bypass grafting. Heart Surg Forum 2007; 10:E439-E444.
33. Popov AF, Hinz J, Schulz EG, et al. The eNOS 786C/T polymorphism in cardiac surgical patients with cardiopulmonary bypass is associated with renal dysfunction. Eur J Cardiothorac Surg 2009; 36:651-656.
34. Haase-Fielitz A, Haase M, Bellomo R, et al. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009; 20:1393-1403.
35. Popov AF, Schulz EG, Schmitto JD, et al. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery. Artif Organs 2010; 34:961-968.
36. Pedroso JA, Paskulin D, Dias FS, et al. Temporal trends in acute renal dysfunction among critically ill patients according to I/D and-262A > T ACE polymorphisms. J Bras Nefrol 2010; 32:182-194.
37. Hagos Y, Wolff NA. Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity. Toxins (Basel) 2010; 2:2055-2082.
38. Filipski KK, Mathijssen RH, Mikkelsen TS, et al. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther 2009; 86:396-402.
39. Druml W, Metnitz B, Schaden E, et al. Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med 2010; 36:1221-1228.
40. Glance LG, Wissler R, Mukamel DB, et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 2010; 113:859-872.
41. Plataki M, Kashani K, Cabello-Garza J, et al. Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol 2011; 6:1744-1751.
42. Billings FT, Pretorius M, Schildcrout JS, et al. Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol 2012; 23:1221-1228.
43. Soto GJ, Frank AJ, Christiani DC, Gong MN. Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med 2012; 40:2601-2608.
44. Kelz RR, Reinke CE, Zubizarreta JR, et al. Acute kidney injury, renal function, and the elderly obese surgical patient: a matched case-control study. Ann Surg 2013; 258:359-363.
45. Chao C-T, Wu V-C, Tsai H-B, et al. Impact of body mass on outcomes of geriatric postoperative acute kidney injury patients. Shock 2014; 41:400-405.
46. Kumar AB, Bridget Zimmerman M, Suneja M. Obesity and postcardiopulmonary bypass-associated acute kidney injury: a single-center retrospective analysis. J Cardiothorac Vasc Anesth 2014; 28:551-556.
47. Suneja M, Kumar AB. Obesity and perioperative acute kidney injury: a focused review. J Crit Care 2014; 29:694.e1-694.e6.
48. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255:821-829.
49. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566-1572.
50. Lobo DN, Stanga Z, Aloysius MM, et al. Effect of volume loading with 1 l intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38:464-470.
51. McCluskey SA, Karkouti K, Wijeysundera D, et al. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 2013; 117:412-421.
52. Hansen PB, Jensen BL, Skott O. Chloride regulates afferent arteriolar contraction in response to depolarization. Hypertension 1998; 32:1066-1070.
53. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256:18-24.
54. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983; 71:726-735.
55. Haase N, Perner A. Hydroxyethyl starch for resuscitation. Curr Opin Crit Care 2013; 19:321-325.
56. Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 2008; 8:1-8.
57. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911.
58. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134.
59. Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0 45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346:f839.
60. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and metaanalysis. JAMA 2013; 309:678-688.
61. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38:368-383.
62. Zerah L, Brocheriou I, Galichon P, et al. Warfarin-related nephropathy: a case report. Rev Med Interne 2013; doi: 10.1016/j.revmed.2013.09.006. [Epub ahead of print]
63. Brodsky SV, Satoskar A, Chen J, et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 2009; 54:1121-1126.
64. van Blijderveen JC, Verhamme KM, Zietse R, et al. Overanticoagulation is associated with renal function decline. J Nephrol 2013; 26:691-698.
65. Shafi ST, Negrete H, Roy P, et al. A case of dabigatran-associated acute renal failure. WMJ 2013; 112:173-175.
66. Ryan M, Ware K, Qamri Z, et al. Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant 2013. [Epub ahead of print]
67. van den Akker JP, Egal M, Groeneveld JA. Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: a systematic review and meta-analysis. Crit Care 2013; 17:R98.
68. Kuiper JW, Vaschetto R, Della Corte F, et al. Bench-to-bedside review: ventilation-induced renal injury through systemic mediator release-just theory or a causal relationship? Crit Care 2011; 15:228.